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GENOME-WIDE ASSOCIATION STUDY OF HALLUX VALGUS: THE
JOHNSTON COUNTY OSTEOARTHRITIS PROJECT
J.M. Jordan 1, S. Smith 1, W. Maixner 1, Y.M. Golightly 1, Y.-H. Hsu 2,
M.T. Hannan 2. 1Univ. of North Carolina, Chapel Hill, NC, USA; 2Harvard
Univ., Boston, MA, USA
Purpose: Hallux valgus (HV) is a common foot disorder with a clinically
suspected genetic predisposition, but virtually no formal genetics assess-
ment. We have recently shown in the Framingham Foot Study that this
condition is highly heritable. We report the ﬁrst genome-wide association
study of HV using data from the Johnston County Osteoarthritis Project
(JoCo OA), a study of OA in a North Carolina county.
Methods: The sample consisted of 916 Caucasian adults (mean age 62.1
[SD 9.0]; 39% men) participating in the ﬁrst follow-up (1999-2004) or
new enrollment cohort (2003-2004) of JoCo OA who contributed blood
for genetic analysis and had data on HV. HV (present/absent) was
determined in the standing position by trained examiners as 'present'
when the angle between the longitudinal axes of hallux and ﬁrst meta-
tarsal was >¼15 degrees and otherwise deﬁned as 'absent'. Genotyping
was performed with Illumina 1M Duo and imputation to w 2.5M SNPs
done with HapMap. Association analyses adjusted for age, sex, BMI, and
recruitment site were performed using logistic regression with General-
ized Estimating Equations on 2,540,970 SNPs after data cleaning and
imputation .
Results: HV was present in 61.8% of the sample. Thirteen SNPs within the
MYH13 gene locus were associated with HV at genome-wide levels of
statistical signiﬁcance (P < 5x10E-8). Other genes located near sugges-
tively associated SNPs include genes previously associated with OA (A2BP1
and GDF5). Among genes suggestively associated with HV, genes involved
in neurocellular development and implicated in neuropathology (DISC1,
NEFL, CNTN5) were well represented.
Conclusion: HV is highly heritable and associated with several SNPs that
have been identiﬁed with OA in other cohorts. Further analysis of these
SNPs, validation in another cohort, and meta-analysis will help assess the
replicability of these ﬁndings and the signiﬁcance of these observations.
That some of these SNPs have been associated with OA supports the
inclusion of HV as a part of the generalized OA phenotype.SNP¼single nucleotide polymorphism; MAF¼minor allele frequency;
chr¼chromosome
SNP GENE MAF Chr Beta P-value
rs12936552 MYH13 0.2176 17 0.85 9.97E-09
rs9432025 DISC1 0.4887 1 -0.56 2.48E-07
rs4787029 A2BP1 0.1763 16 0.73 8.47E-07
rs11598953 PDLIM1 0.4995 10 -0.49 3.62E-06
rs17052934 NEFL 0.1024 8 -0.89 6.59E-06
rs143384 GDF5 0.4491 20 0.52 6.75E-06
rs6589719 CNTN5 0.4327 11 0.5 7.49E-06
rs7507031 COLEC12 0.2588 18 -0.53 7.87E-06390
EPIGENETIC REGULATION OF ELF3 TRANSCRIPTIONAL ACTIVATION IN
HUMAN CHONDROCYTES IN VIVO AND IN VITRO.
K. Hashimoto 1,2, K. El-Hachem 1, M. Otero 1, M.B. Goldring 1. 1Hosp. for
Special Surgery, New York, NY, USA; 2 Tohoku Central Hosp., Yamagata, Japan
Purpose: In osteoarthritis (OA), articular chondrocytes undergo pheno-
typic change and acquire the ability to overexpress matrix-degrading
genes. Our previous studies have shown that the increased expression of
catabolic genes, including MMPs, ADAMTS4 and IL1B, in OA chondrocytes
correlates with demethylation of speciﬁc CpG sites in their promoters.
Further, we have shown that E74-like factor 3 (ELF3) protein levels are
increased in OA cartilage, and that ELF3 contributes to matrixmetalloproteinase 13 (MMP13) expression in chondrocytes, hence sug-
gesting its involvement in cartilage degradative processes. The aims of this
study were 1) to analyze the ELF3 relative expression and promoter
methylation status in non-OA and OA humanprimary chondrocytes, and 2)
to determine whether ELF3 transcriptional activation is affected by its
promoter methylation status in chondrocytes in vitro.
Methods: ELF3 gene expression and the methylation status of its proximal
promoter were assessed by RT-qPCR and bisulﬁte sequencing, respectively,
in isolated healthy (#NOF) and OA human chondrocytes. Two ELF3
promoter constructs (spanning -622/+163 bp and -327/+163 bp) contain-
ing 20 and 18 CpG sites, respectively, were generated by PCR and cloned
into a CpG-free reporter vector. The ELF3 reporter constructs were left
untreated or treated withM.SssIDNAmethyltransferase, tomethylate all of
the CpG sites in the promoter region. Each non-methylated and methyl-
ated reporter construct was transfected into C28/I2 chondrocytes, and the
promoter activities were analyzed by reporter assays. In addition, CpG sites
in the -622/+163 construct were methylated in various patterns using
M.SssI, HhaI and HpaII methyltransferases, and the promoter activities
were analyzed as described.
Results: RT-qPCR analysis revealed increased ELF3 expression in OA
chondrocytes (3-fold) compared to non-OA chondrocytes. Bisulﬁte
sequencing showed increased CpG methylation of the ELF3 proximal
promoter in OA chondrocytes (Figure 1). Methylation treatment sup-
pressed the activities of the -622/+163bp and -322/+163bp ELF3
promoter constructs (11.8 and 8.4-fold, respectively). Further, total or
partial CpG methylation of the -622/+163 bp reporter construct byM.SssI,
HhaI or HpaII lead to a signiﬁcant suppression of the ELF3 promoter
activity.
Conclusions:We here report that the ELF3 gene expression is increased in
OA chondrocytes compared to non-OA chondrocytes, and that the CpG
methylation status of the ELF3 proximal promoter is increased in OA
chondrocytes. On the other hand, in vitro CpG methylation of ELF3 reporter
constructs decreased the ELF3 promoter activities. The latter discrepancy
suggests that the contribution of CpG methylation to the ELF3 promoter
transcriptional control may depend upon themethylation status of speciﬁc
CpG site/s, and that the same events that may block ELF3 transcriptional
repressors may also affect the actions of activators of the ELF3 promoter.
Further investigation is needed to elucidate the relative contribution of the
CpG methylation status to the ELF3 transcriptional control in OA chon-
drocytes, and to deﬁne the transcriptional modulators affected by the
methylation status of the ELF3.Figure 1. The CpG methylation status of the ELF3 proximal promoter in healthy
(#NOF) and OA chondrocytes. promoter.
